Key points are not available for this paper at this time.
// Feng Li 1, 2 , Yong-Ping Zhai 2 , Ting Lai 2 , Qian Zhao 2 , Hui Zhang 1 , Yu-Mei Tang 2 and Jian Hou 1 1 Myeloma and Lymphoma Center, Department of Hematology, Changzheng Hospital, The Second Military Medical University, Shanghai, China 2 Department of Hematology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China Correspondence to: Jian Hou, email: houjian@medmail.com.cn Keywords: t(4;14) translocation, MMSET gene, major breakpoint (MB4), prognosis, bortezomib Received: March 08, 2017 Accepted: May 06, 2017 Published: May 24, 2017 ABSTRACT Multiple myeloma (MM) patients with t(4;14) is a heterogeneous group. Prognostic tools capable of predicting the outcome of patients are currently lacking. The MM SET domain (MMSET) protein is universally overexpressed and has been suggested to have an important tumorigenic role. This study analyzed whether the overexpression of full-length (MB4-1) or truncated forms (MB4-2 and MB4-3) of MMSET influence the prognosis of t(4;14) pos MM patients. A total of 53 symptomatic t(4;14) pos MM patients were retrospectively analyzed. RT-PCR was performed using cDNA from purified CD138+ bone marrow plasma cells to analyze expression and clinical significance of the IGH-MMSET fusion transcripts corresponding to MB4-1, MB4-2 and MB4-3 breakpoints. Among the patients, 25 (47.2%), 12 (22.6%) and 16 (30.2%) had the MB4-1, MB4-2 and MB4-3 breakpoints, respectively. When adjusted to the established prognostic variables including del(17p), ISS stage, serum LDH and serum calcium levels, the pooled MB4-2/MB4-3 subgroup remained a powerful independent adverse factor for PFS ( P =0.013) and OS ( P =0.029). Bortezomib-based therapy significantly improved the survival of the MB4-1 subgroup but could not overcome the negative effect of the MB4-2/MB4-3 breakpoints. Our results indicate that MB4-2/MB4-3 breakpoints with truncated forms of MMSET define a subset of t(4;14) pos MM with poor prognosis.
Li et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: